APO Research
Talk to an analyst

APO RESEARCH · REPORT

Isoxazoline Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Isoxazoline Drugs Market Outlook and Growth Opportunities 2026

30 December 2025195 pages

Choose your research edition.

Industry ResearchIsoxazoline Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Isoxazoline Drugs Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Isoxazoline Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Isoxazoline Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Isoxazoline Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Isoxazoline Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Isoxazoline Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Isoxazoline Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Isoxazoline Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Isoxazoline Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Isoxazoline Drugs market include Zoetis Inc, Nissan Chemical Corporation, Merck Animal Health Inc., Elanco Animal Health Incorporated and Boehringer Ingelheim International GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Isoxazoline Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Isoxazoline Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Isoxazoline Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Isoxazoline Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Isoxazoline Drugs Segment by Company

Zoetis Inc

Nissan Chemical Corporation

Merck Animal Health Inc.

Elanco Animal Health Incorporated

Boehringer Ingelheim International GmbH

Isoxazoline Drugs Segment by Type

Sarolaner

Lotilaner

Fluralaner

Afoxolaner

Others

Isoxazoline Drugs Segment by Application

Dog

Cat

Others

Isoxazoline Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Isoxazoline Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Isoxazoline Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Isoxazoline Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Isoxazoline Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isoxazoline Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Isoxazoline Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isoxazoline Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Isoxazoline Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Isoxazoline Drugs industry.

Chapter 3: Detailed analysis of Isoxazoline Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Isoxazoline Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Isoxazoline Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Isoxazoline Drugs Industry Trends Table 2. Isoxazoline Drugs Industry Drivers Table 3. Isoxazoline Drugs Industry Opportunities and Challenges Table 4. Isoxazoline Drugs Industry Restraints Table 5. Global Isoxazoline Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Isoxazoline Drugs Revenue Share by Company (2021-2026) Table 7. Global Isoxazoline Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Isoxazoline Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Isoxazoline Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Isoxazoline Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Isoxazoline Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Isoxazoline Drugs Company, Product Type & Application Table 13. Global Isoxazoline Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Isoxazoline Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Sarolaner Table 18. Significant Companies of Lotilaner Table 19. Significant Companies of Fluralaner Table 20. Significant Companies of Afoxolaner Table 21. Significant Companies of Others Table 22. Global Isoxazoline Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Isoxazoline Drugs Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Isoxazoline Drugs Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Isoxazoline Drugs Sales Volume Share by Type (2021-2026) Table 26. Global Isoxazoline Drugs Sales Volume Share by Type (2027-2032) Table 27. Global Isoxazoline Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Isoxazoline Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Isoxazoline Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Isoxazoline Drugs Sales Value Share by Type (2021-2026) Table 31. Global Isoxazoline Drugs Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Dog Table 33. Significant Companies of Cat Table 34. Significant Companies of Others Table 35. Global Isoxazoline Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Isoxazoline Drugs Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Isoxazoline Drugs Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Isoxazoline Drugs Sales Volume Share by Application (2021-2026) Table 39. Global Isoxazoline Drugs Sales Volume Share by Application (2027-2032) Table 40. Global Isoxazoline Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Isoxazoline Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Isoxazoline Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Isoxazoline Drugs Sales Value Share by Application (2021-2026) Table 44. Global Isoxazoline Drugs Sales Value Share by Application (2027-2032) Table 45. Global Isoxazoline Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Isoxazoline Drugs Sales by Region (2021-2026) & (K Units) Table 47. Global Isoxazoline Drugs Sales Market Share by Region (2021-2026) Table 48. Global Isoxazoline Drugs Sales by Region (2027-2032) & (K Units) Table 49. Global Isoxazoline Drugs Sales Market Share by Region (2027-2032) Table 50. Global Isoxazoline Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Isoxazoline Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Isoxazoline Drugs Sales Value Share by Region (2021-2026) Table 53. Global Isoxazoline Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Isoxazoline Drugs Sales Value Share by Region (2027-2032) Table 55. Global Isoxazoline Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Isoxazoline Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Isoxazoline Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Isoxazoline Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Isoxazoline Drugs Sales by Country (2021-2026) & (K Units) Table 60. Global Isoxazoline Drugs Sales Market Share by Country (2021-2026) Table 61. Global Isoxazoline Drugs Sales by Country (2027-2032) & (K Units) Table 62. Global Isoxazoline Drugs Sales Market Share by Country (2027-2032) Table 63. Global Isoxazoline Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Isoxazoline Drugs Sales Value Market Share by Country (2021-2026) Table 65. Global Isoxazoline Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Isoxazoline Drugs Sales Value Market Share by Country (2027-2032) Table 67. Zoetis Inc Company Information Table 68. Zoetis Inc Business Overview Table 69. Zoetis Inc Isoxazoline Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Zoetis Inc Isoxazoline Drugs Product Portfolio Table 71. Zoetis Inc Recent Development Table 72. Nissan Chemical Corporation Company Information Table 73. Nissan Chemical Corporation Business Overview Table 74. Nissan Chemical Corporation Isoxazoline Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Nissan Chemical Corporation Isoxazoline Drugs Product Portfolio Table 76. Nissan Chemical Corporation Recent Development Table 77. Merck Animal Health Inc. Company Information Table 78. Merck Animal Health Inc. Business Overview Table 79. Merck Animal Health Inc. Isoxazoline Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Merck Animal Health Inc. Isoxazoline Drugs Product Portfolio Table 81. Merck Animal Health Inc. Recent Development Table 82. Elanco Animal Health Incorporated Company Information Table 83. Elanco Animal Health Incorporated Business Overview Table 84. Elanco Animal Health Incorporated Isoxazoline Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Elanco Animal Health Incorporated Isoxazoline Drugs Product Portfolio Table 86. Elanco Animal Health Incorporated Recent Development Table 87. Boehringer Ingelheim International GmbH Company Information Table 88. Boehringer Ingelheim International GmbH Business Overview Table 89. Boehringer Ingelheim International GmbH Isoxazoline Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Boehringer Ingelheim International GmbH Isoxazoline Drugs Product Portfolio Table 91. Boehringer Ingelheim International GmbH Recent Development Table 92. Key Raw Materials Table 93. Raw Materials Key Suppliers Table 94. Isoxazoline Drugs Distributors List Table 95. Isoxazoline Drugs Customers List Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Isoxazoline Drugs Product Image Figure 2. Global Isoxazoline Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Isoxazoline Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Isoxazoline Drugs Sales (2021-2032) & (K Units) Figure 5. Global Isoxazoline Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Isoxazoline Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Sarolaner Image Figure 10. Lotilaner Image Figure 11. Fluralaner Image Figure 12. Afoxolaner Image Figure 13. Others Image Figure 14. Global Isoxazoline Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Isoxazoline Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Isoxazoline Drugs Sales Volume Share by Type (2021-2032) Figure 17. Global Isoxazoline Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Isoxazoline Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Isoxazoline Drugs Sales Value Share by Type (2021-2032) Figure 20. Dog Image Figure 21. Cat Image Figure 22. Others Image Figure 23. Global Isoxazoline Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Isoxazoline Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Isoxazoline Drugs Sales Volume Share by Application (2021-2032) Figure 26. Global Isoxazoline Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Isoxazoline Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Isoxazoline Drugs Sales Value Share by Application (2021-2032) Figure 29. Global Isoxazoline Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Isoxazoline Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Isoxazoline Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Isoxazoline Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Isoxazoline Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. North America Isoxazoline Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Isoxazoline Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Isoxazoline Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Isoxazoline Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Isoxazoline Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Isoxazoline Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. South America Isoxazoline Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Isoxazoline Drugs Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Isoxazoline Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Isoxazoline Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Isoxazoline Drugs Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Isoxazoline Drugs Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Sarolaner
  • Lotilaner
  • Fluralaner
  • Afoxolaner
  • Others
Applications
  • Dog
  • Cat
  • Others
Companies covered
  • Zoetis Inc
  • Nissan Chemical Corporation
  • Merck Animal Health Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Isoxazoline Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Isoxazoline Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Isoxazoline Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Isoxazoline Drugs Market Dynamics
  1. 2.1 Isoxazoline Drugs Industry Trends
  2. 2.2 Isoxazoline Drugs Industry Drivers
  3. 2.3 Isoxazoline Drugs Industry Opportunities and Challenges
  4. 2.4 Isoxazoline Drugs Industry Restraints
3 Isoxazoline Drugs Market by Company
  1. 3.1 Global Isoxazoline Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Isoxazoline Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Isoxazoline Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Isoxazoline Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Isoxazoline Drugs Company Ranking (2024-2026)
  6. 3.6 Global Isoxazoline Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Isoxazoline Drugs Company Product Type and Application
  8. 3.8 Global Isoxazoline Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Isoxazoline Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Isoxazoline Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Isoxazoline Drugs Market by Type
  1. 4.1 Isoxazoline Drugs Type Introduction
  2. 4.1.1 Sarolaner
  3. 4.1.2 Lotilaner
  4. 4.1.3 Fluralaner
  5. 4.1.4 Afoxolaner
  6. 4.1.5 Others
  7. 4.2 Global Isoxazoline Drugs Sales Volume by Type
  8. 4.2.1 Global Isoxazoline Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Isoxazoline Drugs Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Isoxazoline Drugs Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Isoxazoline Drugs Sales Value by Type
  12. 4.3.1 Global Isoxazoline Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Isoxazoline Drugs Sales Value by Type (2021-2032)
  14. 4.3.3 Global Isoxazoline Drugs Sales Value Share by Type (2021-2032)
5 Isoxazoline Drugs Market by Application
  1. 5.1 Isoxazoline Drugs Application Introduction
  2. 5.1.1 Dog
  3. 5.1.2 Cat
  4. 5.1.3 Others
  5. 5.2 Global Isoxazoline Drugs Sales Volume by Application
  6. 5.2.1 Global Isoxazoline Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Isoxazoline Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Isoxazoline Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Isoxazoline Drugs Sales Value by Application
  10. 5.3.1 Global Isoxazoline Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Isoxazoline Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Isoxazoline Drugs Sales Value Share by Application (2021-2032)
6 Isoxazoline Drugs Regional Sales and Value Analysis
  1. 6.1 Global Isoxazoline Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Isoxazoline Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Isoxazoline Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Isoxazoline Drugs Sales by Region (2027-2032)
  5. 6.3 Global Isoxazoline Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Isoxazoline Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Isoxazoline Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Isoxazoline Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Isoxazoline Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Isoxazoline Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Isoxazoline Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Isoxazoline Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Isoxazoline Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Isoxazoline Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Isoxazoline Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Isoxazoline Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Isoxazoline Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Isoxazoline Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Isoxazoline Drugs Sales Value Share by Country, 2025 VS 2032
7 Isoxazoline Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Isoxazoline Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Isoxazoline Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Isoxazoline Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Isoxazoline Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Isoxazoline Drugs Sales by Country (2027-2032)
  6. 7.4 Global Isoxazoline Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Isoxazoline Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Isoxazoline Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Isoxazoline Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Isoxazoline Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Isoxazoline Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis Inc
  2. 8.1.1 Zoetis Inc Company Information
  3. 8.1.2 Zoetis Inc Business Overview
  4. 8.1.3 Zoetis Inc Isoxazoline Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Inc Isoxazoline Drugs Product Portfolio
  6. 8.1.5 Zoetis Inc Recent Developments
  7. 8.2 Nissan Chemical Corporation
  8. 8.2.1 Nissan Chemical Corporation Company Information
  9. 8.2.2 Nissan Chemical Corporation Business Overview
  10. 8.2.3 Nissan Chemical Corporation Isoxazoline Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Nissan Chemical Corporation Isoxazoline Drugs Product Portfolio
  12. 8.2.5 Nissan Chemical Corporation Recent Developments
  13. 8.3 Merck Animal Health Inc.
  14. 8.3.1 Merck Animal Health Inc. Company Information
  15. 8.3.2 Merck Animal Health Inc. Business Overview
  16. 8.3.3 Merck Animal Health Inc. Isoxazoline Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Animal Health Inc. Isoxazoline Drugs Product Portfolio
  18. 8.3.5 Merck Animal Health Inc. Recent Developments
  19. 8.4 Elanco Animal Health Incorporated
  20. 8.4.1 Elanco Animal Health Incorporated Company Information
  21. 8.4.2 Elanco Animal Health Incorporated Business Overview
  22. 8.4.3 Elanco Animal Health Incorporated Isoxazoline Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Elanco Animal Health Incorporated Isoxazoline Drugs Product Portfolio
  24. 8.4.5 Elanco Animal Health Incorporated Recent Developments
  25. 8.5 Boehringer Ingelheim International GmbH
  26. 8.5.1 Boehringer Ingelheim International GmbH Company Information
  27. 8.5.2 Boehringer Ingelheim International GmbH Business Overview
  28. 8.5.3 Boehringer Ingelheim International GmbH Isoxazoline Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Boehringer Ingelheim International GmbH Isoxazoline Drugs Product Portfolio
  30. 8.5.5 Boehringer Ingelheim International GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Isoxazoline Drugs Value Chain Analysis
  2. 9.1.1 Isoxazoline Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Isoxazoline Drugs Sales Mode & Process
  6. 9.2 Isoxazoline Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Isoxazoline Drugs Distributors
  9. 9.2.3 Isoxazoline Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst